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cinoma 
E. Fiori. A. De Cesare. G. Calati. M. Borioni. N. D'Andrea. A. Barbarosos. L. Izzo and A. Bolognese 
Dept. of General Surgery "Pietro Valdoni", University of Rome "La Sapienza", Rome, ltaly 
Surgery remains thè preferred tlierapy for renai celi carcinoma. The various adjunctive or complementary thera- pies 
currently yield disappointing rcsults. Idcntifying reliablc prognostic factors could help in selecting patients most likely 
to benefit from postoperative adjuvant therapies. 
Wc rcvicwcd thè surgical records of 78 patients who had undergone radicai nephrectomy with lymphadenectomy for 
renai celi carcinoma, matched for typc of operation and histology. According to staging (TNM), 5.1% of thè patients 
were classitied as stage I, 51.3% as stage II, 29.5% as stage III and 14.5% as stage IV. Of thc 78 patients 40 were T,N() 
and 21 T,aN(). Tumor grading showed that 39.7% of thè patients had well-differentiated tu- mors(G(), 41.1 % 
moderately-differentiated (G,), and 19.2% poorly-differentiated tumors (G,). 
Overall actuarial survival at 5 and IO years was 100% for stage I; 91.3% at 5 years and 83.1% al 10 years for stage II; 
45.5% and 34.1% for stage III; and 29.1% and nil for stage IV (stage II vs stage III p = 0.0001). Patients with tumors 
confined to thè kidney (pT,N(|) had better 5- and 10-year survival rates tlian patients with tumors infiltrating thè 
pcrircnal fat (pTvN0) (p = 0.000006). Survival differed according to nuclear grading (G, vs G3 ; p = 0.000005; G, vs G,; 
p = 0.0009). 
In conclusion our review idcntified tumor stage, primary-lumor extension. and thc grado of nuclear differentiation as 
reliablc prognostic factors in patients with renai celi carcinomas. 
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Surgery remains thc only treatment for localized kid-
ney carcinomas. Complementary or adjuvant therapies 
(chemotherapy, radiation, hormones and immunothera- 
py) seem of doubtful therapcutic benefit after radicai 
surgery (R0). To identify patients who stand a chance of 
benefitting from adjuvant therapy, more information is 
needed on unfavorable prognostic factors. 
The clinica! and morphologic variables most closely 
related lo survival are tumor diameter, thè histopatholog- 
ical subtype, tlie grade of cellular differentiation (G), pri- 
mary-tumor extension (T), lymph-node involvement, renai 
vein involvement, thè metastatic site, tumor-cell DNA 
content (ploidy), celi nucleus morphomctry and 
determination of tlie nuclear area. In this study we 
assessed thè importance of primary-tumor extension and 
grade of differentiation as prognostic factors in patients 
who had undergone radicai nephrectomy for renai carci-
noma. 
Materials and Mcthods 
From thè case records of thè Ist Department of Gen-
eral Surgery at thè University of Rome, "La Sapienza", 
ltaly. we selected a group of 78 patients (47 men, age 
range 16-83 years) who had undergone surgery for renai 
celi carcinoma from 1980 to 1998 and who had regular 
follow-up, similar operations and similar histopathologi- 
cal findings. In 39 patients thc tumor involvcd thc right 
kidney. All patients underwent a renai ultrasound exam- 
ination followed by computed tomographic (CT) scan or 
magnetic resonance imaging (MRI) to confimi thè diag- 
nosis and stage thè tumor clinically. All patients treated
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early on in thè series underwent urography and some also 
had selective renai artery arteriography. All patients also 
had scintigraphic scans to assess renai fìinction, particu- 
larly in thè contralateral kidney. 
The surgical approach was a midiine laparotomy. In all 
cases surgery consisted of a radicai nephrectomy including 
thè adrenal gland. perirenal fat and Gerola's fascia, with a 
lymphadenectomy extending to thè pre-lat- eral-retroaortic 
territories for thè left kidney or thè pre- latcral and 
retrocaval territories for thè right kidney, then from thè 
infradiaphragmatic crus to thè iliac bifurcation and to thè 
interaorto-caval territory. All patients had clear-cell renai 
carcinomas. According to postoperative assessment of thè 
anatomical extent (thè pathologic stage) and grade of thè 
tnmor using thè Tumor-Node- 
 
Metastasis classification of thè 1997 edition of thè Inter-
national Union against Cancer, 4 out of thè 78 patients 
(5.1%) had stage I tumore; 40 (51.3%) stage II tumore; 23 
(29.5%) stage Ili tumore (21 tumore were T,viN() and 2 
were T1bN,); and 11 (14.1%) stage IV tumore (Table I). 
Tumor grading for celi differcntiation showed that 31 
patients (39.7%) had well-differentiated tumore^,); 32 
(41.1%) moderately-dififerentiated (G2); and 15 (19.2%) 
poorly-differentiated tumore (G,) (Table II). Of thè 40 
patients with T,N(| tumore, 20 were G, and 19 G, and of 
thè 21 patients with T3aN() 9 tumore were G, and 10 Gv All 
78 patients were available for long-tenn postoperative 
follow-up (range, 24 to 236 months after surgery). The 
Kaplan-Meier method was used to estimate actuarial 
survival in relation to stage, primary- tuinor exlension and 
grade, and thè curves for thè various groups were 
comparcd by thè log-rank test. 
Results
 
None of thè operations led to postoperative morbidi- ty 
or mortai ity. 
Overall actuarial survival at 5 years and 10 years was 
100% for stage I; 91.3% and 83.1% for stage II; 45.5% 
and 34.1% for stage III and 29.1% and 0 for stage IV, 
respectively. There was no significant ditìference in sur-
vival between slages I and II or belween stages III and IV. 
Patients with stage II tumore survived significantly longer 
tlian those with stage III tumore (p = 0.0001 ) (Figure 1). 
Survival dilTered signifìcantly in thè 40 patients 
whose tumore remained confined within thè kidney 
(pT,N(l) and thè 21 with malignanl extension to thè 
perirenal fat (pT,aN0) (91.3% vs 36.8 % at 5 years; and 
83.1 % vs 22.1% at 10 years; p = 0.000006) (Figure 2). 
No significant dilTerences were found for 5- and 10-year 
survival rates between patients with well-differentiated 
and those with moderately-dififerentiated tumore (82.6% 
vs 76.5% at 5 years; 66.7% vs 73.4% at 10 years). Con- 
vereely, survival at 5 and at 10 years dififered significant-
Tahle I - Renai celi carcinoma - Stage 
Stage N.PTS. % 
1 4 5.1 
II 
(pT2NO) 
40 51.3 
111 23 29.5 
(pT3aNo) 21  
(pT3N 1 ) 2  
IV 11 14.1 
78 pis. (1980-1998 ) 
 
I - Renai celi Carcinoma - Grading 
 
N.PTS % 
Gl 31 39.7 
G2 32 41.1 
G3 15 19.2 
78 pts. (1980-1998) 
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ly in patients with G, and in those with G, tumors (p = 
0.00005) (none of thè G, group survived at 5 years) and 
also between patients with G, and those with G, tumors (p 
= 0.009) (Figure 3). Stage being equal, we found no 
significant differences between survival in patients with G, 
and those with G, tumors. 
Discussion 
Primary-tumor extension is an important prognostic 
Factor in patients with renai celi carcinoma. In patients 
without lymph-node metastases. most investigators report 
better survival rates in patients with tumors con- fined lo 
thè kidney (T,-T,) than in those with tumor extension 
outside thè organ (T,-T4) (1-6). though not all studies 
contimi this llnding (7). 
A review of thè literature showed that according to 
histologic tumor grade of nuclear differentiation, tumors in 
higher grades (G.) metaslasize more often than those in 
lower grades (G, and G,), with no significant differences 
between G, and G, (f, 8-14). 
The data we report herc underlinc thè prognostic 
importance of primary-tumor extension; even in patients 
with no lymph-node involvement, tumors involving thè 
perirenal fat (Th) bave a signilicantly worse prognosis than 
those confined to thè kidney. 
Also in our patients, thè grade of ccllular dilTcrcntia- 
tion had no influence on survival at lcast for well-differ- 
entiated or moderalely-differentiated tumors, whereas
poorly-differentiated tumors had a significantly worse 
prognosis. 
The absence of lymph-node metastases cannot be 
considered a favorable prognostic sign when thè tumor has 
extended beyond thè kidney (15-18). One reason is that 
renai carcinoma rarely sprcads via thè lymphalic route 
(only 6-32% of illese patients bave lymph-node 
metastases) ( 19-22), in our case series 11.5%. Sccond. 
kidney lymphalic drainage varics and cali involve distant 
lymph-node stations whilc rcgional lympli nodes remain 
heallhy (23-25). In our series, one patient with a T3(N0 
tumor had distant metastases in thè mediastinal lympli 
nodes. 
A wide lymphadcncctomy remains a uselul procedure 
that provides more precise information l'or histopatho- 
logical staging without increasing morbidity or mortality. 
Whelhcr adjuvanl therapy improves thè prognosis of 
patients who bave T, tumors with grade 3 differentiation 
sliould be detemiined in randomized prospective studies. 
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